APA (7th ed.) Citation

MY, H., JR, C., PC, T., CY, C., AC, L., HY, Y., . . . SC, L. (2025). Knockdown of Derlin-1 Represses Cellular Oncogenic Activities in Uveal Melanoma, Enhances its Chemosensitivity to Cisplatin and Reduces Cancer Stem Cell Potential. Cancer genomics & proteomics, 22(5), 809. https://doi.org/10.21873/cgp.20538

Chicago Style (17th ed.) Citation

MY, Hsieh, Chen JR, Tsai PC, Chen CY, Liu AC, Yeh HY, Chen WT, Wu CY, and Li SC. "Knockdown of Derlin-1 Represses Cellular Oncogenic Activities in Uveal Melanoma, Enhances Its Chemosensitivity to Cisplatin and Reduces Cancer Stem Cell Potential." Cancer Genomics & Proteomics 22, no. 5 (2025): 809. https://doi.org/10.21873/cgp.20538.

MLA (9th ed.) Citation

MY, Hsieh, et al. "Knockdown of Derlin-1 Represses Cellular Oncogenic Activities in Uveal Melanoma, Enhances Its Chemosensitivity to Cisplatin and Reduces Cancer Stem Cell Potential." Cancer Genomics & Proteomics, vol. 22, no. 5, 2025, p. 809, https://doi.org/10.21873/cgp.20538.